MedTrace Logo

Intermittent Versus Continuous Renal Replacement Therapy for Acute Renal Failure

NCT00322933 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1628

Last updated 2006-10-26

No results posted yet for this study

Summary

This multicentre SHARF4 (Stuivenberg Hospital Acute Renal Failure) study aims to investigate outcome in patients with acute renal failure (ARF), stratified according to severity of disease (SHARF score) and randomised to different treatment options.

All adult patients with a serum creatinine \>2 mg/dl were included. Patients were stratified according to disease severity and those in need for RRT were randomised to intermittent (IRRT) or continuous renal replacement therapy (CRRT)

Conditions

  • Renal Insufficiency, Acute
  • Renal Replacement Therapy

Interventions

PROCEDURE

renal replacement therapy (intermittent or continuous)

Sponsors & Collaborators

  • Ziekenhuis Netwerk Antwerpen (ZNA)

    lead OTHER

Principal Investigators

  • Robert L Lins, MD PhD · Ziekenhuis Netwerk Antwerpen (ZNA)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-04-30
Completion
2005-03-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00322933 on ClinicalTrials.gov